Off‐label use of rituximab in autoimmune disease in the Top End of the Northern Territory, 2008–2016

E-ISSN： 1445-5994|48|2|165-172

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.48, Iss.2, 2018-02, pp. : 165-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality, Safety and Efficacy in the ‘Off-Label’ Use of Medicines

Current Drug Safety, Vol. 2, Iss. 1, 2007-01 ,pp. : 89-95

Bentham Science Publishers

Access to resources Recommend Favorite

Off‐Label Use of Medicines: Time for Action

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 157-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Off-label drug use ‐ price analysis for Avastin ® in ophthalmology

By Michels Stephan Kurz-Levin Malaika Schmitz Christian

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 3, Iss. 1, 2009-04 ,pp. : 59-73

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Deleted: Requirement for Pharmacist Review of Off-Label Medication Use

JCAH Perspectives, Vol. 31, Iss. 3, 2011-03 ,pp. : 4-4

Joint Commission Resources

Access to resources Recommend Favorite

FDA issues warning about off‐label pediatric use of tramadol

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 17, Iss. 11, 2015-11 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite